Clinical Trial: Vertically Coronally Advanced Flap Versus Coronally Advanced Flap for Miller Class I Gingival Recession

U.S., Aug. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07763093) titled 'Vertically Coronally Advanced Flap Versus Coronally Advanced Flap for Miller Class I Gingival Recession' on Aug. 08.

Brief Summary: This randomized controlled clinical trial aims to compare the clinical effectiveness of the Vertically Coronally Advanced Flap (VCAF) and the Coronally Advanced Flap (CAF), both combined with connective tissue graft (CTG) and enamel matrix derivative (EMD), for the treatment of Miller Class I gingival recession. Twenty-six Miller Class I gingival recession defects will be randomly assigned in a 1:1 ratio to either the VCAF + CTG + EMD group or the CAF + CTG + EMD group. Clinical outcomes, including mean...